Zim Laboratories Share Price
126.55-1.47 (-1.15%)
+67.28% past 1 Year
News
Zim Laboratories Q1 FY earnings show sharp EBITDA and margin compression
Equity
ZIMLAB
Zim Lab reports wider first quarter loss as revenue rises sharply
Equity
ZIMLAB
Zim Laboratories informs about newspaper advertisements
Equity
ZIMLAB
Zim Laboratories informs about newspaper publication
Equity
ZIMLAB
ZIM Laboratories secures marketing authorization for ‘Dabigatran Etexilate’ in Italy
Equity
ZIMLAB
Zim Laboratories - Quaterly Results
Equity
ZIMLAB
Zim Laboratories reports Profit after tax of 3.28 Crores, in the March 2026 quarter
Equity
ZIMLAB
Zim Laboratories reported sharp year-on-year decline in Q4 EBITDA and margin performance
Equity
ZIMLAB
Zim Laboratories Q4 FY earnings show softer profit and revenue performance YoY
Equity
ZIMLAB
Zim Laboratories informs about acquisition of equity shares of ZIMTAS
Equity
ZIMLAB
ZIM Laboratories invests Rs 89.45 lakh in ZIMTAS
Equity
ZIMLAB
Zim Laboratories informs about disclosure
Equity
ZIMLAB
Zim Laboratories informs about proceedings of EGM
Equity
ZIMLAB
Zim Laboratories gets nod to incorporate subsidiary in Chile
Equity
ZIMLAB
Zim Laboratories reports Profit after tax of 4.26 Crores, in the December 2025 quarter
Equity
ZIMLAB
Zim Laboratories informs about outcome of board meeting
Equity
ZIMLAB
Zim Laboratories Board Approves Issuance of Up to 47,64,497 Shares at Rs 73.46 to Florintree Trinex LLP.
Equity
ZIMLAB
Zim Laboratories informs about press release
Equity
ZIMLAB
ZIM Laboratories gets CDSCO’s approval for Naproxen plus Esomeprazole Capsules
Equity
ZIMLAB
Zim Laboratories informs about conference call
Equity
ZIMLAB